the future of cardiovascular implantable devices

A free repsonsive template by webflow
sign upLearn more

a new approach

polymeric devices for better longevity and performance

vascular grafts

The next generation of vascular grafts with first-in-class features for children and adults

Learn more

heart valves

Solving the problems of today's heart valves with tomorrow's polymeric leaflets

Learn more

radiopaque vascular grafts

A free repsonsive template by webflow

what we do

radiopaque vascuLAr graft

what we do

radiopaque vascuLAr graft

polymeric
construction

Our polymeric material platform enables new functionalities without compromising performance and usability

advanced
visualization

The only vascular graft on the market to provide radiopaque indicators to enable advanced noninvasive visualization

proven
performance

Thousands of implants to date with excellent results underscore PECA's commitment to patient safety

controllably-expandable vascular graft

A free repsonsive template by webflow

what we do

CONTROLLably-Expandable vascuLAr graft

pre-implant
customization

Pre-implant customization allows for flaring and tapering for anatomical match and improved hemodynamics

post-implant
expansion

Controllable expandability post-implant can provide growth potential and help relieve stenosis

advanced
visualization

Radiopaque indicators provide advanced noninvasive visualization not available in other polymeric grafts

Not Yet Available In Your Region

what we do

polymeric anti-thrombogenic vascular graft

what we do

POLYMERIC ANTI-THROMBOGENIC VASCULAR graft

extremely
bioinert

Our proprietary polymer material platform provides a highly bio-inert surface to reduce thrombosis and hyperplasia

doesn't
wear off

Our polymer platform provides a bio-inert surface inherent to the material, without pharmaceutical coatings that wear off

polymeric
construction

Our polymeric material platform enables new functionalities without compromising perfromance and usability

Not Yet Available In Your Region

what we do

polymeric pulmonary valved conduit

what we do

POLYMERIC pulmonary valved conduit

polymeric
construction

Our polymeric material platform enables new functionalities without compromising performance and usability

bi-leaflet
design

MASA Valve features a proprietary bi-leaflet valve designed for the unique anatomy of pulmonary reconstruction

usa clinical
trial ongoing

MASA Valve is currently being evaluated in a prospective USA clinical trial, with successful first-in-human implant complete.

Not Yet Available In Your Region

what we do

polymeric transcatheter aortic valve

what we do

POLYMERIC transcatheter aortic valve

polymeric construction

Our polymeric material platform enables new functionalities without compromising performance and usability

slim delivery system

Fully-polymeric leaflets enable a slimmed-down delivery system to reduce the chance vascular injury

proven performance

STEALTH utilizes our clinically-proven polymer material platform, providing excellent performance and durability

Not Yet Available In Your Region

what we do

we are
Founded by a group of Carnegie Mellon alumni including a pediatric surgeon, PECA Labs is revolutionizing cardiovascular implantable devices with a polymer platform and a novel design approach.

what we do

Executive Management

doug
bernstein
ceo

Co-Founder
Forbes 30 Under 30
Carnegie Mellon MechE & BioE

Dr. Arush
Kalra
CSO

Co-Founder
Pediatric Surgeon
Carnegie Mellon BioE

Jamie
Quinterno
COO

Co-Founder
Forbes 30 Under 30
Carnegie Mellon Business

what we do

BOARD of directors

Dr. Jeffrey
Carpenter
ceo

Founding Chairman, Dept. Surgery at Cooper
Chief of Surgery at Cooper U Healthcare
Serial Entrepreneur & Inventor
Tech Sold to Edwards, Terumo, Cook

Jeffrey
O'donnell sr.
CSO

Serial Entrepreneur, >5 Exits / IPOs
Managing Director of Runway Healthcare
CEO at Embrella through sale to Edwards
Fmr. Board Chairman at Endologix

Samuel
Navarro
COO

Managing Partner at Gravitas Healthcare
Fmr. Managing Director at Cowen & Co.
Fmr. Manager of. Galleon Healthcare Fund
Wharton MBA, Stanford MS

JonathAn
Kuhn
mascot

Managing Partner at Allegheny Financial Group
Managing Partner at Allegheny Investments
Certified Financial Planner
Named Who's Who in America Finance & Industry

babs
carryer
CSO

Co-Founder of LaunchCyte
Serial Entrepreneur
Fmr. Director Pitt Big Idea Center
Fmr. Prof. Entrepreneurship at Carnegie Mellon

Brandon
Haynes
COO

Managing Partner at Allegheny Financial Group
Named 40 Under 40 Investment Advisors
Certified Financial Planner
Managing Partner at Allegheny Investments

Michael
Moriarty
ceo

Member of Blue Tree Allied Capital
Fmr. Fedex Services Sales Officer
Serial Sales and Logistics Executive
Thee Decades in Ops, Sales and Supply Chain

Doug
BernstEIN
CSO

Co-Founder & CEO of PECA Labs
Congenital Defect Survivor
Forbes 30 Under 30
Carnegie Mellon MechE & BioE

what we do

TEAM

Dr. blue
martin
senior r&D
Engineer

Co-Founder
Forbes 30 Under 30
Carnegie Mellon MechE & BioE

Paul
harter
manager
of sales

Co-Founder
Pediatric Surgeon
Carnegie Mellon BioE

daniela
rivero
quality
Control

Co-Founder
Forbes 30 Under 30
Carnegie Mellon Business

Megan
Kronz
Project
manager

Co-Founder
Forbes 30 Under 30
Carnegie Mellon MechE & BioE

Dharani
Annadurai
regulatory
affairs

Co-Founder
Pediatric Surgeon
Carnegie Mellon BioE

Alex
getchell
micro-
biology

Co-Founder
Forbes 30 Under 30
Carnegie Mellon Business

what we do

news

MASA Valve First-In-HUMan Implant

June 2023 - Children’s Hospital of Philadelphia, a world-renowned children’s hospital and research institute, became the first site in the world to implant a MASA Valve in a pediatric patient. This marks a significant milestone in PECA Labs’ mission to bring the first polymeric pulmonary valve to market and improve outcomes for patients.

3 Luminaries Join PECA Labs board

May 2023 - PECA Labs has announced it has added Dr. Jeffrey P. Carpenter, Jeffrey O’Donnell, Sr. and Samuel E. Navarro to its board of directors. The new board members will help guide the company as it develops and commercializes cardiovascular implants based on its novel tunable polymeric material platform.

MASA Valve Trial Begins Enrollment

April 2023 - PECA Labs  announced the U.S. Food and Drug Administration (FDA) granted an Investigational Device Exemption (IDE) for an early feasibility study (EFS) of its MASA Valve. The MASA Valve is a polymeric valved conduit for pulmonary valve reconstruction. The company has begun enrollment for the study at five clinical sites across the U.S.

what we do

the first vascualr graft with radiopaque indicators

Tab Section

the first polymeric vascular graft with radiopaque indicators

Some Title Here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Heading

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.
Duis cursus, mi quis viverra ornare, eros dolor interdum nulla, ut commodo diam libero vitae erat.
Aenean faucibus nibh et justo cursus id rutrum lorem imperdiet. Nunc ut sem vitae risus tristique posuere.

Founded by a group Carnegie Mellon alumni including a pediatric surgeon, PECA Labs is revolutionizing cardiovascular implantable devices with a polymer platform and a novel design approach.